Somatic alterations in lung cancer: Do environmental factors matter?

被引:29
作者
Gibelin, Cecilia [1 ]
Couraud, Sebastien [1 ,2 ]
机构
[1] Univ Lyon 1, Fac Med Lyon Sud, Ciblage Therapeut Oncol EMR3738, F-69600 Oullins, France
[2] Hosp Civils Lyon, Inst Cancerol, Serv Pneumol Aigue Specialisee & Cancerol Thorac, CH Lyon Sud, F-69310 Pierre Benite, France
关键词
Lung cancer; Somatic alteration; Risk factors; TP53; EGFR; KRAS; GROWTH-FACTOR RECEPTOR; TOBACCO-SMOKE; AIR-POLLUTION; KRAS MUTATIONS; RADON EXPOSURE; DRIVER MUTATIONS; 2ND-HAND SMOKE; P53; MUTATIONS; NEVER-SMOKERS; LIFE-STYLE;
D O I
10.1016/j.lungcan.2016.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is the leading cause of cancer-related death worldwide and smoking tobacco is now definitively established as the dominant risk factor for the malignancy. However, lung cancer can and does occur in never smokers, thus illustrating the existence of other risk factors. Many of these latter are environmental, such as workplace and home carcinogens, air pollution, radon and certain infectious agents. One of the most remarkable advances in thoracic oncology is the recent identification of somatic oncogenic molecular abnormalities, some of which are candidates for targeted therapies. Active smoking is now known to cause a particular somatic profile distinct from that found in never-smokers. This has logically led researchers to consider the possibility that exposure to other lung cancer risk factors may also engender a unique somatic profile. Thus, with the present work, we sought to review current knowledge on somatic profiles in the setting of bronchial cancer (for targetable mutations such as EGFR, ALK, BRAF and HER2, as well as some non-targetable mutations such as TP53, and KRAS) and their associations with environmental risk factors for the malignancy. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 68 条
[61]  
Wild P., 2012, BR J CANC, V106
[62]  
World Health Organization-International Agency for Research on Cancer, 2016, AG CLASS IARC MON, V1-112
[63]   Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice [J].
Yamaguchi, Norihiro ;
VanderLaan, Paul A. ;
Folch, Erik ;
Boucher, David H. ;
Canepa, Hannah M. ;
Kent, Michael S. ;
Gangadharan, Sidharta P. ;
Majid, Adnan ;
Kocher, Olivier N. ;
Goldstein, Michael A. ;
Huberman, Mark S. ;
Costa, Daniel B. .
LUNG CANCER, 2013, 82 (01) :31-37
[64]   Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation [J].
Yang, Q ;
Wesch, H ;
Mueller, KM ;
Bartsch, H ;
Wegener, K ;
Hollstein, M .
BRITISH JOURNAL OF CANCER, 2000, 82 (04) :763-766
[65]   Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer [J].
Ying, Hongyan ;
Yang, Xian-Da ;
Sun, Zhao ;
Ning, Xiaohong ;
Wang, Yingyi ;
Bai, Chunmai ;
Chen, Shuchang ;
Wang, Yuzhou .
MEDICAL ONCOLOGY, 2014, 31 (10) :1-7
[66]   Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women [J].
Yu, Ignatius T. S. ;
Chiu, Yuk-lan ;
Au, Joseph S. K. ;
Wong, Tze-wai ;
Tang, Jin-ling .
CANCER RESEARCH, 2006, 66 (09) :4961-4967
[67]   Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer [J].
Yu, Xian-Jun ;
Yang, Min-Jun ;
Zhou, Bo ;
Wang, Gui-Zhen ;
Huang, Yun-Chao ;
Wu, Li-Chuan ;
Cheng, Xin ;
Wen, Zhe-Sheng ;
Huang, Jin-Yan ;
Zhang, Yun-Dong ;
Gao, Xiao-Hong ;
Li, Gao-Feng ;
He, Shui-Wang ;
Gu, Zhao-Hui ;
Ma, Liang ;
Pan, Chun-Ming ;
Wang, Ping ;
Chen, Hao-Bin ;
Hong, Zhi-Peng ;
Wang, Xiao-Lu ;
Mao, Wen-Jing ;
Jin, Xiao-Long ;
Kang, Hui ;
Chen, Shu-Ting ;
Zhu, Yong-Qiang ;
Gu, Wen-Yi ;
Liu, Zi ;
Dong, Hui ;
Tian, Lin-Wei ;
Chen, Sai-Juan ;
Cao, Yi ;
Wang, Sheng-Yue ;
Zhou, Guang-Biao .
EBIOMEDICINE, 2015, 2 (06) :583-590
[68]  
Zeeb H, 2009, WHO HANDBOOK ON INDOOR RADON: A PUBLIC HEALTH PERSPECTIVE, P1